140 related articles for article (PubMed ID: 3028608)
21. Increased TGFbeta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells.
Turco A; Scarpa S; Coppa A; Baccheschi G; Palumbo C; Leonetti C; Zupi G; Colletta G
Exp Cell Res; 2000 Feb; 255(1):77-85. PubMed ID: 10666336
[TBL] [Abstract][Full Text] [Related]
22. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
23. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Takahashi H; Simizu B
Cancer Res; 1993 Jul; 53(13):3179-85. PubMed ID: 8319227
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma.
Scarpa S; Coppa A; Ragano-Caracciolo M; Mincione G; Giuffrida A; Modesti A; Colletta G
Exp Cell Res; 1996 Nov; 229(1):147-54. PubMed ID: 8940258
[TBL] [Abstract][Full Text] [Related]
25. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
26. Sustained cytokine production and immunophenotypic changes in human neuroblastoma cell lines transduced with a human gamma interferon vector.
Uçar K; Seeger RC; Challita PM; Watanabe CT; Yen TL; Morgan JP; Amado R; Chou E; McCallister T; Barber JR
Cancer Gene Ther; 1995 Sep; 2(3):171-81. PubMed ID: 8528960
[TBL] [Abstract][Full Text] [Related]
27. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
Isaacs JS; Hardman R; Carman TA; Barrett JC; Weissman BE
Cell Growth Differ; 1998 Jul; 9(7):545-55. PubMed ID: 9690622
[TBL] [Abstract][Full Text] [Related]
28. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Hopkins-Donaldson S; Bodmer JL; Bourloud KB; Brognara CB; Tschopp J; Gross N
Cancer Res; 2000 Aug; 60(16):4315-9. PubMed ID: 10969767
[TBL] [Abstract][Full Text] [Related]
29. [Human neuroblastoma cell lines having smooth muscle cell markers].
Sugimoto T; Ueyama H; Hosoi H; Inazawa J; Mine H; Matsumura T; Fushiki S; Kato T; Miyake M; Sawada T
Hum Cell; 1991 Sep; 4(3):248-56. PubMed ID: 1782184
[TBL] [Abstract][Full Text] [Related]
30. Modulation of cell surface antigens accompanies morphological differentiation of human neuroblastoma cell lines.
Reynolds CP; Maples J
Prog Clin Biol Res; 1985; 175():13-37. PubMed ID: 2986170
[No Abstract] [Full Text] [Related]
31. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
[TBL] [Abstract][Full Text] [Related]
32. Differential drug sensitivity of human neuroblastoma cells.
Spengler BA; Ross RA; Biedler JL
Cancer Treat Rep; 1986 Aug; 70(8):959-65. PubMed ID: 3731152
[TBL] [Abstract][Full Text] [Related]
33. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J
Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
[TBL] [Abstract][Full Text] [Related]
34. Human granulocyte surface molecules identified by murine monoclonal antibodies.
Skubitz KM; Pessano S; Bottero L; Ferrero D; Rovera G; August JT
J Immunol; 1983 Oct; 131(4):1882-8. PubMed ID: 6619543
[TBL] [Abstract][Full Text] [Related]
35. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation.
Peterson S; Bogenmann E
Oncogene; 2004 Jan; 23(1):213-25. PubMed ID: 14712226
[TBL] [Abstract][Full Text] [Related]
36. Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells.
Marshall GM; Cheung B; Stacey KP; Camacho ML; Simpson AM; Kwan E; Smith S; Haber M; Norris MD
Oncogene; 1995 Aug; 11(3):485-91. PubMed ID: 7630632
[TBL] [Abstract][Full Text] [Related]
37. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
38. [Significance of neuronal acetylcholine receptors as differentiation antigens in neuroblastomas and paragangliomas].
Marx A; Geuder KI; Altmannsberger M; Schömig E; Kirchner T; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():354-8. PubMed ID: 1708612
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
40. Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis.
Piacentini M; Piredda L; Starace DT; Annicchiarico-Petruzzelli M; Mattei M; Oliverio S; Farrace MG; Melino G
J Pathol; 1996 Dec; 180(4):415-22. PubMed ID: 9014863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
